Companies » Company Overview » Ranbaxy Laboratories Ltd.
 
 
  • BSE: 500359
  • NSE: RANBAXY
  • ISIN Code: INE015A01028
  • Sector: Health care
bse
859.90
45.80 (5.63%)
Open 814.90
Day High 869.00
Day Low 810.30
Previous Close 814.10
Volume 308222
52-Week high 869.00
52-Week low 429.25
P/E -
Mkt Cap.(Rs cr) 36603
NSE

859.80
45.80 (5.63%)
Bse

859.90
45.80 (5.63%)
nse
859.80
45.80 (5.63%)
Open 814.70
Day High 869.70
Day Low 809.45
Previous Close 814.00
Volume 5415702
52-Week high 869.70
52-Week low 429.05
P/E -
Mkt Cap.(Rs cr) 36603

Ranbaxy Laboratories Ltd. (RANBAXY) - Company Information

Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The company has a global footprint in 46 countries, world-class manufacturing facilities in 8 countries and serves customers in over 125 count... [More]

Key Fundamentals
Market Cap (Rs cr) 36,603
EPS - TTM (Rs)

[*C]

-
P/E Ratio (x)

[*C]

-
Face Value (Rs) 5
Latest Dividend (%) 40.00
Latest Dividend Date 28 Apr 2011
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*C]

77.51
P/B Ratio (x)

[*C]

11.09
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
810.30
869.00
Week Low/High
0.00
869.00
Month Low/High
792.00
869.00
YEAR Low/High
429.25
869.00
All TIME Low/High
4.75
869.00
Peer Group
Company Last Change(%)
Dr Reddy's Labs 3651.15 -0.82
Cipla 680.30 0.23
Aurobindo Pharma 1334.75 -5.71
Ranbaxy Labs. 859.90 5.63
Cadila Health. 1739.30 -2.75
Glaxosmit Pharma 3255.10 -1.81
Divi's Lab. 1890.10 0.06
Returns
Period Ranbaxy Labs. Sensex NIFTY
1 Week NA -1.51% -1.99%
1 Month 5.38% -1.02% -1.34%
3 Month 32.72% 1.14% 1.08%
6 Month 45.43% 8.94% 10.62%
1 Year 83.50% 25.69% 26.94%
3 Year 69.12% 63.86% 62.69%
Period Ranbaxy Labs. Sensex NIFTY
1 Week NA -1.51% -1.99%
1 Month 5.36% -1.02% -1.34%
3 Month 32.56% 1.14% 1.08%
6 Month 45.36% 8.94% 10.62%
1 Year 83.54% 25.69% 26.94%
3 Year 69.14% 63.86% 62.69%
Financial Results
Particulars (Rs cr) Dec 2014 Dec 2013 %Chg
Net Sales 2618.85 2893.99 -9.51
Other Income 10.68 138.8 -92.31
Total Income 2629.53 3032.8 -13.3
Total Expenses 2521.24 2881.08 -12.49
Operating Profit 108.29 151.72 -28.63
Net Profit -1023.61 -158.49 -545.85
Equity Capital 212.24 211.55 -
SHAREHOLDING PATTERN
As on Dec 2014
Research Reports
Date Broker Action Price Report
28/01 Motilal Oswal Buy 700 PDF Icon
28/01 IDFC Outperform 700 PDF Icon
03/11 Angel Broking Neutral 634 PDF Icon
28/10 Motilal Oswal Buy 634 PDF Icon
28/10 Prabhudas Lilladhar Accumulate 634 PDF Icon
Company information
Director : Takashi Shoda
Chairman : Tsutomu Une
Director : Rajesh V Shah
Company Secretary : S K Patawari
Managing Director & CEO : Arun Sawhney
Director : Anthony H Wild
Director : Akihiro Watanabe
Director : Kazunori Hirokawa
Director : Percy K Shroff
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME: MNC Associate
Registered office
Plot No 90, Sector 32,
Gurgaon,Haryana-122001
Ph: 91-0124-4135000
E-mail:
URL: http://www.ranbaxy.com

Quick Links

Quick Links for Ranbaxy Laboratories

Back to Top